全文获取类型
收费全文 | 26814篇 |
免费 | 1988篇 |
国内免费 | 81篇 |
专业分类
耳鼻咽喉 | 287篇 |
儿科学 | 622篇 |
妇产科学 | 570篇 |
基础医学 | 3623篇 |
口腔科学 | 921篇 |
临床医学 | 3022篇 |
内科学 | 5229篇 |
皮肤病学 | 259篇 |
神经病学 | 2908篇 |
特种医学 | 1006篇 |
外国民族医学 | 2篇 |
外科学 | 3328篇 |
综合类 | 402篇 |
一般理论 | 24篇 |
预防医学 | 2239篇 |
眼科学 | 582篇 |
药学 | 2222篇 |
中国医学 | 21篇 |
肿瘤学 | 1616篇 |
出版年
2023年 | 94篇 |
2021年 | 312篇 |
2020年 | 265篇 |
2019年 | 367篇 |
2018年 | 419篇 |
2017年 | 392篇 |
2016年 | 424篇 |
2015年 | 529篇 |
2014年 | 736篇 |
2013年 | 1111篇 |
2012年 | 1698篇 |
2011年 | 1876篇 |
2010年 | 1069篇 |
2009年 | 938篇 |
2008年 | 1743篇 |
2007年 | 1720篇 |
2006年 | 1713篇 |
2005年 | 1818篇 |
2004年 | 1661篇 |
2003年 | 1616篇 |
2002年 | 1532篇 |
2001年 | 359篇 |
2000年 | 304篇 |
1999年 | 366篇 |
1998年 | 351篇 |
1997年 | 262篇 |
1996年 | 238篇 |
1995年 | 281篇 |
1994年 | 233篇 |
1993年 | 199篇 |
1992年 | 241篇 |
1991年 | 200篇 |
1990年 | 198篇 |
1989年 | 205篇 |
1988年 | 187篇 |
1987年 | 190篇 |
1986年 | 202篇 |
1985年 | 203篇 |
1984年 | 205篇 |
1983年 | 201篇 |
1982年 | 225篇 |
1981年 | 191篇 |
1980年 | 198篇 |
1979年 | 147篇 |
1978年 | 163篇 |
1977年 | 142篇 |
1976年 | 119篇 |
1975年 | 109篇 |
1974年 | 105篇 |
1973年 | 95篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Lukas Rimas V. Thakkar Jigisha P. Cristofanilli Massimo Chandra Sunandana Sosman Jeffrey A. Patel Jyoti D. Kumthekar Priya Stupp Roger Lesniak Maciej S. 《Journal of neuro-oncology》2022,156(3):443-452
Journal of Neuro-Oncology - Leptomeningeal metastases (LM) constitute an involvement of cancer which is associated with marked morbidity and mortality. The contemporary diagnostic and therapeutic... 相似文献
2.
Antabe Roger Sano Yujiro Luginaah Isaac 《Zeitschrift fur Gesundheitswissenschaften》2022,30(3):537-544
Journal of Public Health - Married women face one of the highest HIV rates in Malawi. Although HIV misconceptions have been identified as a major contributor to HIV infection, we know very little... 相似文献
3.
4.
Roger Jankowski 《Anatomical record (Hoboken, N.J. : 2007)》2022,305(8):1857-1870
The process by which upper respiratory tract structures have changed over deep evolutionary time is, in part, reflected in the process of embryologic development. The nasopharynx in particular is a centrally located space bounded by components of the respiratory portion of the nasal cavity, cranial base, soft palate, and Eustachian tube. The development of these components can be understood both in terms of embryologic structures such as the branchial arches and paraxial mesoderm and through fossil evidence dating as far back as the earliest agnathan fish of the Cambrian Period. Understanding both the evolution and development of these structures has been an immeasurable benefit to the otolaryngologist seeking to model disease etiology of both common and rare conditions. This discussion is a primer for those who may be unfamiliar with the central importance of the nasopharynx both in terms of our evolutionary history and early embryological development of vital cranial and upper respiratory tract structures. 相似文献
5.
Eva-Maria Grbner Michael Zeiler Florian Ph. S. Fischmeister Kathrin Kollndorfer Sonja Schmelz Andrea Schneider Nina Haid-Stecher Kathrin Sevecke Gudrun Wagner Lara Keller Roger Adan Unna Danner Annemarie van Elburg Benny van der Vijgh Karlijn Liselotte Kooij Serguei Fetissov Nadia A. Andreani John F. Baines Astrid Dempfle Jochen Seitz Beate Herpertz-Dahlmann Andreas Karwautz 《European eating disorders review》2022,30(1):61-74
6.
Michael Mark Dirk Klingbiel Ulrich Mey Ralph Winterhalder Christian Rothermundt Silke Gillessen Roger von Moos Michael Pollak Gabriela Manetsch Räto Strebel Richard Cathomas 《Clinical genitourinary cancer》2019,17(2):e323-e328
Background
There is evidence linking metformin to improved prostate cancer–related outcomes.Patients and Methods
Twenty-five men with metastatic castration-resistant prostate cancer and prostate-specific antigen (PSA) progression while receiving treatment with abiraterone from 3 Swiss centers were included in this single-arm phase 2 trial between November 2013 and September 2016. Metformin was added to abiraterone continuously at 1000 mg twice daily in uninterrupted 4-week cycles. The primary end point was the absence of disease progression at 12 weeks (PFS12). The Fleming single-stage design was applied. With a 5% significance level and 80% power, 25 patients were required to test PFS12 ≤ 15% (H0) compared to ≥ 35% (H1). Secondary end points included toxicity and safety issues. The study was registered at ClinicalTrials.gov (NCT01677897).Results
The primary end point PFS12 was 12% (3 of 25 patients) (95% confidence interval, 3-31). Most patients had PSA progression, almost half had radiographic progression, but only 1 patient had symptomatic progression. Eleven (44%) of 25 patients had grade 1 and 2 patients each grade 2 (8%) or grade 3 (8%) gastrointestinal toxicity (nausea, diarrhea, loss of appetite). One patient discontinued treatment at week 5 because of intolerable grade 3 diarrhea.Conclusion
The addition of metformin to abiraterone for patients with metastatic castration-resistant prostate cancer and PSA progression while receiving abiraterone therapy does not affect further progression and has no meaningful clinical benefit. A higher-than-expected gastrointestinal toxicity attributed to metformin was observed. 相似文献7.
8.
Roger Blanks Andrea Burón Pust Rupert Alison Emily He Isobel Barnes Julietta Patnick Gillian K Reeves Sarah Floud Valerie Beral Jane Green 《International journal of cancer. Journal international du cancer》2019,145(3):728-734
Faecal occult blood (FOB) - based screening programmes for colorectal cancer detect about half of all cancers. Little is known about individual health behavioural characteristics which may be associated with screen-detected and interval cancers. Electronic linkage between the UK National Health Service Bowel Cancer Screening Programme (BCSP) in England, cancer registration and other national health records, and a large on-going UK cohort, the Million Women Study, provided data on 628,976 women screened using a guaiac-FOB test (gFOBt) between 2006 and 2012. Relative risks (RRs) and 95% confidence intervals (CIs) were estimated by logistic and Cox regression for associations between individual lifestyle factors and risk of colorectal tumours. Among screened women, 766 were diagnosed with screen-detected colorectal cancer registered within 2 years after a positive gFOBt result, and 749 with interval colorectal cancers registered within 2 years after a negative gFOBt result. Current smoking was significantly associated with risk of interval cancer (RR 1.64, 95%CI 1.35–1.99) but not with risk of screen-detected cancer (RR 1.03, 0.84–1.28), and was the only factor of eight examined to show a significant difference in risk between interval and screen-detected cancers (p for difference, 0.003). Compared to screen-detected cancers, interval cancers tended to be sited in the proximal colon or rectum, to be of non-adenocarcinoma morphology, and to be of higher stage. 相似文献
9.
Nur Zeinomar Kelly-Anne Phillips Mary B. Daly Roger L. Milne Gillian S. Dite Robert J. MacInnis Yuyan Liao Rebecca D. Kehm Julia A. Knight Melissa C. Southey Wendy K. Chung Graham G. Giles Sue-Anne McLachlan Michael L. Friedlander Prue C. Weideman Gord Glendon Stephanie Nesci kConFab Investigators Irene L. Andrulis Saundra S. Buys Esther M. John John L. Hopper Mary Beth Terry 《International journal of cancer. Journal international du cancer》2019,145(2):370-379
Benign breast disease (BBD) is an established breast cancer (BC) risk factor, but it is unclear whether the magnitude of the association applies to women at familial or genetic risk. This information is needed to improve BC risk assessment in clinical settings. Using the Prospective Family Study Cohort, we used Cox proportional hazards models to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association of BBD with BC risk. We also examined whether the association with BBD differed by underlying familial risk profile (FRP), calculated using absolute risk estimates from the Breast Ovarian Analysis of Disease Incidence and Carrier Estimation Algorithm (BOADICEA) model. During 176,756 person-years of follow-up (median: 10.9 years, maximum: 23.7) of 17,154 women unaffected with BC at baseline, we observed 968 incident cases of BC. A total of 4,704 (27%) women reported a history of BBD diagnosis at baseline. A history of BBD was associated with a greater risk of BC: HR = 1.31 (95% CI: 1.14–1.50), and did not differ by underlying FRP, with HRs of 1.35 (95% CI: 1.11–1.65), 1.26 (95% CI: 1.00–1.60), and 1.40 (95% CI: 1.01–1.93), for categories of full-lifetime BOADICEA score <20%, 20 to <35%, ≥35%, respectively. There was no difference in the association for women with BRCA1 mutations (HR: 1.64; 95% CI: 1.04–2.58), women with BRCA2 mutations (HR: 1.34; 95% CI: 0.78–2.3) or for women without a known BRCA1 or BRCA2 mutation (HR: 1.31; 95% CI: 1.13–1.53) (pinteraction = 0.95). Women with a history of BBD have an increased risk of BC that is independent of, and multiplies, their underlying familial and genetic risk. 相似文献
10.
Yuhuan Wang Jagdish Zade Sung-Sil Moon William Weldon S.S. Pisal Roger I. Glass Rajeev M. Dhere Baoming Jiang 《Vaccine》2019,37(5):698-704
A parenteral inactivated rotavirus vaccine (IRV) in development could address three problems with current live oral rotavirus vaccines (ORV): their lower efficacy in low and middle-income countries (LMICs), lingering concerns about their association with intussusception, and their requirement for a separate supply chain with large volume cold storage. Adding a new parenteral IRV to the current schedule of childhood immunizations would be more acceptable if it could be combined with another injectable vaccine such as inactivated polio vaccine (IPV). Current plans for polio eradication call for phasing out oral polio vaccine (OPV) and transitioning to IPV, initially in LMICs as a single dose booster after two doses of OPV and ultimately as a two dose schedule. Today in many LMICs, IPV is administered as a standalone vaccine, which involves a separate cold chain and is relatively costly. We therefore tested in two animal models formulations of IPV with IRV to determine whether co-administration might interfere with the immune response to each product and spare antigen dose for both vaccines. Our results demonstrate that IRV when adjuvanted with alum and administered alone or in combination with IPV did not impair the immune responses to either rotavirus or poliovirus serotypes 1, 2 and 3. Similarly, IPV when formulated and administered alone or together with IRV induced comparable levels of neutralizing antibody to poliovirus type 1, 2 and 3. Furthermore, comparable antibody titers were observed in animals vaccinated with low, middle or high dose of IPV or IRV in combination. This dose sparing and the lack of interference between IPV and IRV administered together represent another step to support the further development of this novel combination vaccine for children. 相似文献